| Deimmunized Shiga toxin A subunit scaffolds and cell targeting molecules … |
2023-2-06 |
2023-4-12 |
|
| MHC class I epitope delivering polypeptides |
2022-12-15 |
2023-2-02 |
|
| Proteins comprising binding regions, shiga toxin a subunit effector regions, … |
2022-9-21 |
2022-12-27 |
|
| Cell-targeting molecules comprising de-immunized, shiga toxin a subunit … |
2022-6-29 |
2022-11-10 |
|
| Shiga toxin a subunit effector polypeptides, shiga toxin effector scaffolds, … |
2022-6-08 |
2022-8-01 |
|
| De-immunized, shiga toxin a subunit scaffolds and cell-targeting molecules … |
2022-5-17 |
2022-9-08 |
|
| Protease-cleavage resistant, shiga toxin a subunit effector polypeptides and … |
2022-3-29 |
2022-6-14 |
|
| Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t … |
2022-3-17 |
2022-9-22 |
|
| Pd-l1 binding molecules comprising shiga toxin a subunit scaffolds |
2022-3-15 |
2022-5-01 |
|
| Clinical methods for use of a pd-l1-binding molecule comprising a shiga toxin … |
2021-12-16 |
2022-6-23 |
|
| Her2-targeting molecules comprising de-immunized, shiga toxin a subunit … |
2021-12-06 |
2022-5-26 |
|
| Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t- … |
2021-8-27 |
2022-12-22 |
|
| Clinical methods for use of her2 binding molecules |
2021-7-22 |
2022-1-27 |
|
| Cd38-binding proteins comprising de-immunized shiga toxin a subunit effectors |
2021-7-13 |
2021-8-31 |
|
| Proteins comprising amino-terminal proximal shiga toxin a subunit effector … |
2021-7-07 |
2021-10-15 |
|
| Cd20-binding immunotoxins for inducing cellular internalization and methods … |
2021-6-14 |
2021-7-29 |
|
| Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t- … |
2021-5-11 |
2021-8-19 |
|
| Pd-l1 targeting molecules comprising shiga toxin a subunit scaffolds |
2021-3-17 |
2021-10-21 |
|
| Aziridine-containing DNA alkylating agent |
2021-3-04 |
2021-6-17 |
|
| Method of screening, selecting, and identifying cytotoxic recombinant … |
2020-12-21 |
2021-4-22 |
|
| Uses of cd20-binding molecules and additional therapeutic agents |
2020-11-24 |
2021-5-27 |
|
| Pd-l1-binding molecules comprising shiga toxin a subunit scaffolds |
2020-9-18 |
2021-3-18 |
|
| CD38-BINDING PROTEINS INCLUDING DEIMMUNIZED SHIGA TOXIN SUBUNIT A EFFECTORS |
2020-1-23 |
2021-9-01 |
|
| Anti-cd38 binding domains |
2020-1-23 |
2020-7-23 |
|
| Proteins comprising modified immunoglobulin variable light chains |
2020-1-23 |
2020-7-30 |
|
| Pd-l1 binding proteins |
2019-10-15 |
2020-4-23 |
|
| Light chain kappatization of molecules comprising immunoglobulin domains |
2019-10-15 |
2019-11-27 |
|
| Multivalent CD20-binding molecules comprising Shiga toxin a subunit effector … |
2019-7-18 |
2021-8-31 |
2021-8-31 |
| Th-302 solid forms and methods related thereto |
2018-11-16 |
2019-5-02 |
|
| Administration of hypoxia activated prodrugs and antiangiogenic agents for the … |
2018-8-17 |
2019-2-28 |
|
| Anti-cancer therapies |
2018-7-11 |
2018-11-15 |
|
| Cell-targeting molecules comprising amino-terminus proximal or amino-terminal, … |
2018-6-20 |
2018-10-11 |
|
| Predictive biomarker for hypoxia-activated prodrug therapy |
2017-11-07 |
2018-4-05 |
|
| Administration of hypoxia activated prodrugs in combination with chk1 … |
2017-9-22 |
2017-12-14 |
|
| Administration of hypoxia activated prodrugs in combination with immune … |
2017-7-26 |
2020-4-15 |
|
| Treatment of cancer |
2017-2-27 |
2017-8-17 |
|
| (R)-and (S) -1- (3- (3-N, N- Dimethylaminocarbonyl) phenoxy group -4- nitre … |
2016-11-15 |
2018-7-17 |
|
| Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t- … |
2016-7-25 |
2018-8-30 |
|
| Nitrobenzyl derivatives antitumor and anticancer agent |
2016-4-01 |
2018-6-08 |
|
| DNA alkylating agents |
2016-3-09 |
2018-1-02 |
|
| Administration of glufosfamide for the treatment of cancer |
2016-1-29 |
2016-5-26 |
|
| Predictive biomarker for hypoxia-activated prodrug therapy |
2015-11-18 |
2020-9-01 |
2020-9-01 |
| Cd20-binding proteins comprising shiga toxin a subunit effector regions for … |
2015-3-10 |
2015-9-17 |
|
| Treatment of cancer using hypoxia activated prodrugs |
2014-12-17 |
2015-9-17 |
|
| Predictive biomarker for hypoxia-activated prodrug therapy |
2014-10-28 |
2018-9-11 |
2018-9-11 |
| Treatment of pancreatic cancer with a combination of a hypoxia-acti vated … |
2014-7-23 |
2016-6-01 |
|
| Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy |
2014-6-27 |
2015-10-01 |
|
| Predictive and response biomarker for th-302 anti-cancer therapy |
2014-4-09 |
2016-2-17 |
|
| Triazine compound, pharmaceutical salt, isomer, or hydrate thereof, and … |
2014-1-16 |
2015-8-26 |
|
| Phosphoramidate alkylator prodrugs |
2013-12-10 |
2016-1-05 |
2016-1-05 |
| Library from toxin mutants and methods of using same |
2013-1-11 |
2013-8-01 |
|
| Hypoxia activated prodrugs and mtor inhibitors for treating cancer |
2012-12-20 |
2015-1-01 |
|
| Unit dose form for oral administration |
2012-4-13 |
2014-9-03 |
|
| Be used for the treatment of the method for cancer |
2012-3-30 |
2016-2-10 |
2016-2-10 |
| Compositions and methods for treating cancer |
2012-1-26 |
2012-4-26 |
|
| Administration of hypoxia activated prodrugs and antiangiogenic agents for the … |
2011-7-11 |
2013-2-14 |
|
| Treatment for blood cancer |
2011-6-27 |
2013-8-22 |
|
| Camptothecin derivatives |
2010-6-16 |
2013-11-05 |
2013-11-05 |
| Hypoxia Activated Drugs Of Nitrogen Mustard Alkylators |
2009-5-14 |
2011-8-04 |
|
| Nitroimidazole agents for hypoxia imaging |
2008-4-04 |
2016-7-18 |
2016-7-18 |
| Nitro-imidazole hypoxia imaging agents |
2008-4-04 |
2016-10-11 |
2016-10-11 |
| Phosphoramidate alkylator prodrugs for the treatment of cancer |
2007-12-21 |
2013-10-08 |
2013-10-08 |
| Unit dose form of glufosfamide |
2007-6-04 |
2009-3-18 |
|
| Anthracycline analogs |
2006-6-30 |
2007-3-15 |
|
| Glufosfamide combination therapy |
2006-5-11 |
2008-2-06 |
|
| Lonidamine analogs |
2006-2-08 |
2007-1-18 |
|
| Lonidamine analogs |
2006-2-01 |
2007-2-22 |
|
| Glufosfamide combination therapy |
2005-12-22 |
2011-7-28 |
|
| Compositions and methods for treating cancer |
2005-12-01 |
2006-6-29 |
|
| Methods for cancer imaging |
2005-11-30 |
2006-7-27 |
|
| Topoisomerase Inhibitors and Prodrugs |
2005-11-27 |
2008-9-04 |
|
| Tubulin binding anti cancer agents and prodrugs thereof |
2005-11-17 |
2006-6-01 |
|
| Tubulin binding anticancer agents and prodrugs thereof |
2005-11-17 |
2007-12-26 |
|
| Treatment of cancer with 2-deoxyglucose |
2005-6-30 |
2005-11-03 |
|
| 脱免疫化された志賀毒素ａサブユニット足場及びそれを含む細胞標的化分子 |
2023-2-06 |
2023-4-12 |
|
| Agentes de nitroimidazol para imagenología de hipoxia |
2008-4-04 |
2016-7-18 |
2016-7-18 |